Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

FBLG

FibroBiologics (FBLG)

FibroBiologics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:FBLG
DatumZeitQuelleÜberschriftSymbolFirma
14/03/202513h35GlobeNewswire Inc.Life Science Virtual Investor Forum: Presentations Now Available for Online ViewingNASDAQ:FBLGFibroBiologics Inc
04/03/202514h30GlobeNewswire Inc.FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based TherapeuticsNASDAQ:FBLGFibroBiologics Inc
27/02/202514h30GlobeNewswire Inc.FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing TherapeuticNASDAQ:FBLGFibroBiologics Inc
12/02/202522h01Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:FBLGFibroBiologics Inc
11/02/202506h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FBLGFibroBiologics Inc
07/02/202523h24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FBLGFibroBiologics Inc
05/02/202515h15GlobeNewswire Inc.FibroBiologics to Host In-Person Analyst Day to Provide Research & Development UpdatesNASDAQ:FBLGFibroBiologics Inc
03/02/202515h19Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:FBLGFibroBiologics Inc
30/01/202518h43Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:FBLGFibroBiologics Inc
29/01/202522h43Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:FBLGFibroBiologics Inc
24/01/202522h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FBLGFibroBiologics Inc
22/01/202506h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FBLGFibroBiologics Inc
17/01/202522h05Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:FBLGFibroBiologics Inc
15/01/202506h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FBLGFibroBiologics Inc
14/01/202522h34Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:FBLGFibroBiologics Inc
10/01/202523h22Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:FBLGFibroBiologics Inc
31/12/202422h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FBLGFibroBiologics Inc
30/12/202422h30GlobeNewswire Inc.FibroBiologics Closes Second $5 Million Tranche of $25 Million FinancingNASDAQ:FBLGFibroBiologics Inc
30/12/202422h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBLGFibroBiologics Inc
30/12/202422h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBLGFibroBiologics Inc
30/12/202420h12GlobeNewswire Inc.D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million FinancingNASDAQ:FBLGFibroBiologics Inc
30/12/202414h29Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:FBLGFibroBiologics Inc
23/12/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FBLGFibroBiologics Inc
23/12/202413h55GlobeNewswire Inc.FibroBiologics Announces $25 Million FinancingNASDAQ:FBLGFibroBiologics Inc
20/12/202423h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FBLGFibroBiologics Inc
19/11/202415h15GlobeNewswire Inc.FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of SplenomegalyNASDAQ:FBLGFibroBiologics Inc
14/11/202415h15GlobeNewswire Inc.FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based TherapeuticsNASDAQ:FBLGFibroBiologics Inc
12/11/202422h20GlobeNewswire Inc.FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:FBLGFibroBiologics Inc
12/11/202422h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FBLGFibroBiologics Inc
29/10/202421h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FBLGFibroBiologics Inc
 Showing the most relevant articles for your search:NASDAQ:FBLG